Fig. 4: Electroretinography comparison between treated and untreated eyes at 12-months.
From: Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats
Quantification of average A and B wave amplitudes from each dosage group are shown (a–f). No significant changes were found between treated and untreated amplitudes for A or B waves (Multiple T-tests, p > 0.05 all groups. N = 11, 8, and 10 for low, medium, and high dose respectively. Box plot elements: mean = +, centerline = median, box limits = 25th and 75th percentiles, whiskers = min and max).
